249 related articles for article (PubMed ID: 7512319)
21. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.
Bird TD; Kraft GH; Lipe HP; Kenney KL; Sumi SM
Ann Neurol; 1997 Apr; 41(4):463-9. PubMed ID: 9124803
[TBL] [Abstract][Full Text] [Related]
23. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
[TBL] [Abstract][Full Text] [Related]
24. Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B.
Kulkens T; Bolhuis PA; Wolterman RA; Kemp S; te Nijenhuis S; Valentijn LJ; Hensels GW; Jennekens FG; de Visser M; Hoogendijk JE
Nat Genet; 1993 Sep; 5(1):35-9. PubMed ID: 7693130
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
[TBL] [Abstract][Full Text] [Related]
26. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A.
Kamholz J; Shy M; Scherer S
Ann Neurol; 1994 Sep; 36(3):451-2. PubMed ID: 8080259
[No Abstract] [Full Text] [Related]
27. Molecular basis of hereditary neuropathies.
Chance PF
Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
[TBL] [Abstract][Full Text] [Related]
28. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
[TBL] [Abstract][Full Text] [Related]
29. Congenital pes cavus in a Charcot-Marie-tooth disease type 1A newborn.
Fusco C; Frattini D; Scarano A; Giustina ED
Pediatr Neurol; 2009 Jun; 40(6):461-4. PubMed ID: 19433282
[TBL] [Abstract][Full Text] [Related]
30. Inherited neuropathies: Charcot-Marie-Tooth disease and related disorders.
Chance PF; Lupski JR
Baillieres Clin Neurol; 1994 Aug; 3(2):373-85. PubMed ID: 7952853
[TBL] [Abstract][Full Text] [Related]
31. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
[TBL] [Abstract][Full Text] [Related]
32. Expression profiling of sciatic nerve in a Charcot-Marie-Tooth disease type 1a mouse model.
ten Asbroek AL; Verhamme C; van Groenigen M; Wolterman R; de Kok-Nazaruk MM; Baas F
J Neurosci Res; 2005 Mar; 79(6):825-35. PubMed ID: 15672449
[TBL] [Abstract][Full Text] [Related]
33. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
[TBL] [Abstract][Full Text] [Related]
34. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
Barisić N; Mihatov I
Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease.
Tang B; Liu X; Zhao G; Luo W; Xia K; Pan Q; Cai F; Hu Z; Zhang C; Chen B; Zhang F; Shen L; Zhang R; Jiang H
Arch Neurol; 2005 Aug; 62(8):1201-7. PubMed ID: 16087758
[TBL] [Abstract][Full Text] [Related]
36. Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families.
Mostacciuolo ML; Righetti E; Zortea M; Bosello V; Schiavon F; Vallo L; Merlini L; Siciliano G; Fabrizi GM; Rizzuto N; Milani M; Baratta S; Taroni F
Hum Mutat; 2001; 18(1):32-41. PubMed ID: 11438991
[TBL] [Abstract][Full Text] [Related]
37. Cochlear implantation in a patient with deafness induced by Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathies).
Postelmans JT; Stokroos RJ
J Laryngol Otol; 2006 Jun; 120(6):508-10. PubMed ID: 16772060
[TBL] [Abstract][Full Text] [Related]
38. Peripheral nerve extracellular matrix remodeling in Charcot-Marie-Tooth type I disease.
Palumbo C; Massa R; Panico MB; Di Muzio A; Sinibaldi P; Bernardi G; Modesti A
Acta Neuropathol; 2002 Sep; 104(3):287-96. PubMed ID: 12172915
[TBL] [Abstract][Full Text] [Related]
39. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside.
Li J; Bai Y; Ghandour K; Qin P; Grandis M; Trostinskaia A; Ianakova E; Wu X; Schenone A; Vallat JM; Kupsky WJ; Hatfield J; Shy ME
Brain; 2005 May; 128(Pt 5):1168-77. PubMed ID: 15774502
[TBL] [Abstract][Full Text] [Related]
40. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene.
Hayasaka K; Himoro M; Sato W; Takada G; Uyemura K; Shimizu N; Bird TD; Conneally PM; Chance PF
Nat Genet; 1993 Sep; 5(1):31-4. PubMed ID: 7693129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
